4.7 Article

Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

Validation of Aztreonam-Avibactam Susceptibility Testing Using Digitally Dispensed Custom Panels

Eric Ransom et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Review Immunology

Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations

Jason M. Pogue et al.

CLINICAL INFECTIOUS DISEASES (2019)

Article Microbiology

In Vitro Activity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013

Douglas J. Biedenbach et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

Article Immunology

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections

Matthew E. Falagas et al.

EMERGING INFECTIOUS DISEASES (2014)

Article Multidisciplinary Sciences

Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor

David E. Ehmann et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)